FF News Logo
Sunday, February 22, 2026
FFNews x MoneyLIVE

Source’s Biotech ETF almost Doubles in Size the day after US Presidential Election

Source saw its market-leading biotech ETF almost double in size the day after the US presidential election as investors returned to the sector.

There was USD 170 million of inflows into the Source NASDAQ Biotech UCITS ETF on Wednesday (9 November), taking assets under management to USD 370 million.

Chris Mellor, Executive Director, Equities Product Management, Source, commented: “Biotech stocks declined 22% between the start of 2016 and the US presidential election, with investors anticipating hostile legislation from another President Clinton.

Instead, a full Republican sweep sent stock prices soaring – our Source NASDAQ Biotech UCITS ETF returned 9% on November 9th. Biotech companies stand to benefit not just from looser regulation but also from the potential of a tax holiday on cash repatriation, last seen in 2004.

The virtual doubling in size of our biotech product and on-exchange spreads remaining tight at around 0.20% demonstrated that this is a high capacity, high performance product.

Active Biotech managers have systematically underperformed the benchmark. Over the last five years the top three active products trailed the NASDAQ Biotech Index by an average of 3.6% per annum. The Source NASDAQ Biotech UCITS ETF performs consistently in line with the index less an ongoing charge of 0.40%.

unnamed-1

  1. Bluefin and Basis Theory Partner to Enable Unified Tokenization Across Digital and In-Person Payments Read more
  2. Invest Bank and AUTON8 Build Partnership to Drive Digital Resilience and Banking Agility Read more
  3. ING’s AI Roadmap: Platform, People, and Agentic AI Read more
  4. UK-fintech Provided Over £17.5m in Emergency Wage Advances to More Than 55,000 Employees in the Last Year Read more
  5. TreviPay Announces AI-Powered Growth Center to Help Enterprises Predict Buyer Behavior and Drive B2B Sales Read more
EMEA2026 x FFnews
More On